CTOs on the Move


 
e4e is an IT-enabled Services and Business Process Outsourcing company that has deep domain and contextual expertise in the US Healthcare Business Services ecosystem, with an enviable client list of reputed companies.   e4e was founded in 2000 and has over 2,500 employees globally, with offices in the U.S., India, and the Philippines. With over 150 years of cumulative senior management experience, we have the capability of delivering compelling business value to our clients, right shoring between our geographical sites and our best practices.
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million
  • www.e4e.com
  • 502 Washington Ave Ste 200
    Towson, MD USA 21204
  • Phone: 443.275.1632

Executives

Name Title Contact Details

Similar Companies

Bodyport

Bodyport is the platform for health in the home. Understand your body on a deeper level. Predict and prevent disease.

Infusion Systems

Infusion Systems is a Valencia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Trius Therapeutics Inc.

Trius Therapeutics Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Diego, CA. To find more information about Trius Therapeutics Inc., please visit www.triusrx.com

Effingham Healthcare System

Provide every patient an experience of compassion, quality care, and service excellence at its highest level of customer expectation. Effingham Health is taking local healthcare to the next level by empowering patients to make their own healthcare decisions. We provide state-of-the-art facilities and technology, which are attracting the best physicians and specialists in the region.

Histogenics

Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Histogenics` regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Histogenics` first investigational product candidate, NeoCart®, leverages its platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.